FAS and hepatocellular carcinoma: Other authors discovered that AITC inhibited the activity of the sterol regulatory element (SRE)-containing FAS promoter in human hepatoma Huh-7/FAS-luc cells reducing SREBPs target gene expression as well as de novo fatty acid and cholesterol synthesis.